Dr. Kurt Bock - Net Worth and Insider Trading
Dr. Kurt Bock Net Worth
The estimated net worth of Dr. Kurt Bock is at least $0 dollars as of 2024-11-08. Dr. Kurt Bock is the Supervisory Board of Basf SE and owns about 0 shares of Basf SE (XTER:BAS) stock worth over $0. Details can be seen in Dr. Kurt Bock's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dr. Kurt Bock has not made any transactions after 2024-04-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dr. Kurt Bock
Dr. Kurt Bock Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dr. Kurt Bock owns 1 companies in total, including Basf SE (XTER:BAS) .
Click here to see the complete history of Dr. Kurt Bock’s form 4 insider trades.
Dr. Kurt Bock Latest Holdings Summary
Dr. Kurt Bock currently owns a total of 1 stock. Dr. Kurt Bock owns 0 shares of Basf SE (XTER:BAS) as of April 26, 2024, with a value of $0.
Dr. Kurt Bock Form 4 Trading Tracker
According to the SEC Form 4 filings, Dr. Kurt Bock has made a total of 2 transactions in Basf SE (XTER:BAS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Basf SE is the acquisition of 2,581 shares on April 26, 2024, which cost Dr. Kurt Bock around $124,963.
Insider Trading History of Dr. Kurt Bock
- 1
Dr. Kurt Bock Trading Performance
GuruFocus tracks the stock performance after each of Dr. Kurt Bock's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dr. Kurt Bock is -2.51%. GuruFocus also compares Dr. Kurt Bock's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dr. Kurt Bock within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dr. Kurt Bock's insider trading performs compared to the benchmark.
Performance of Dr. Kurt Bock
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.56 | | | | | |
| Relative Return to S&P 500(%) | -2.99 | | | | | |
Dr. Kurt Bock Ownership Network
Ownership Network List of Dr. Kurt Bock
Ownership Network Relation of Dr. Kurt Bock
Dr. Kurt Bock Owned Company Details
What does Basf SE do?
Who are the key executives at Basf SE?
Dr. Kurt Bock is the Supervisory Board of Basf SE. Other key executives at Basf SE include Board of Directors Dr. Dirk Elvermann , Board of Directors Dr. Katja Scharpwinkel , and Supervisory Board Prof. Dr. Stefan Asenkerschbaumer .
Basf SE (XTER:BAS) Insider Trades Summary
Over the past 18 months, Dr. Kurt Bock made 1 insider transaction in Basf SE (XTER:BAS) with a net purchase of 2,581. Other recent insider transactions involving Basf SE (XTER:BAS) include a net purchase of 9,350 shares made by Dr. Dirk Elvermann , a net purchase of 11,200 shares made by Dr. Stephan Kothrade , and a net purchase of 21,277 shares made by Dr. Markus Kamieth .
In summary, during the past 3 months, insiders sold 0 shares of Basf SE (XTER:BAS) in total and bought 1,300 shares, with a net purchase of 1,300 shares. During the past 18 months, 0 shares of Basf SE (XTER:BAS) were sold and 51,710 shares were bought by its insiders, resulting in a net purchase of 51,710 shares.
Basf SE (XTER:BAS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Basf SE Insider Transactions
Dr. Kurt Bock Mailing Address
Above is the net worth, insider trading, and ownership report for Dr. Kurt Bock. Currently GuruFocus does not have mailing address information for Dr. Kurt Bock.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
